Table 2 Patient and clinical characteristics
Variable | Total population N = 120 (%) |
|---|---|
Sex | |
 Female | 99 (82.5) |
 Male | 21 (17.5) |
Age | |
 <  45 years | 29 (24.2) |
 45–65 years | 65 (54.2) |
 >  65 years | 26 (21.7) |
Marital status | |
 Single | 16 (13.3) |
 Married | 69 (57.5) |
 Divorced/living separated | 24 (20.0) |
 Widowed | 11 (9.2) |
Educational level | |
 Compulsory/lower secondary | 31 (25.8) |
 Secondary school/apprenticeship | 68 (56.7) |
 Higher education | 9 (7.5) |
 Other | 12 (10.0) |
Monthly net income | |
 <  1.000€ (1120$) | 23 (19.2) |
 1.001–2000 € (1121–2240 $) | 68 (56.7) |
 2001–3000 € (224—3360 $) | 20 (16.7) |
 >  3000€ (>  3361$) | 9 (7.5) |
Disease duration | |
 >  10 years | 35 (42.5) |
 5–10 years | 40 (33.3) |
 1–4 years | 34 (30.8) |
 <  1 year | 8 (6.7) |
RA treatment | |
 NSAID | 51 (42.5) |
 sDMRAD | 106 (88.3) |
 bDMRAD | 38 (31.7) |
 Steroid | 29 (24.2) |
 Other | 11 (9.2) |
Additional medication | |
 No other medication | 34 (28.3) |
 1–2 other medications | 45 (37.5) |
 3–4 other medications | 19 (37.5) |
 >  4 other medications | 22 (18.3) |
Presence of co-morbidity | 62 (51.7) |
| Â | Mean (SD) |
Patient self–assessed (VAS) | 37.8 (30.3) |
 Disease activity | 34.7 (29.4) |
 Pain | 40.8 (29.0) |
 Functional disability | 38.3 (31.0) |
Fatigue | |